Nuclear receptors control gene transcription by binding to specifi cpromoter regions of DNA in the presence of ligand. Orphan nuclear receptors are nuclear receptors for which the endogenous ligand(s) has yet to be identified. Systematic evaluation of orphan nuclear receptors can elucidate species differences in xenobiotic metabolism in addition to aiding in identification of endogenous ligands. The receptor-binding affinity and specifi city of various chemicals, with subsequent determination of the genes controlled by nuclear receptors, are goals of investigations into orphan nuclear receptor structure/function and can provide valuable tools in predicting drug interactions and toxicity.
Cattley RC, DeLuca J., Elcombe C., Fenner-Crisp P., Lake BG, Mars-man DS, Pastoor TA, Popp JA, Robinson DE, Schwetz B., Tugwood J., Wahli W. (1998). Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?Regul Toxicol Pharmacol27: 47—60.
2.
Cheema SK, Agellon LB (2000). The murine and human cholesterol 7alpha-hydroxylase gene promoters are differentially responsive to regulation by fatty acids mediated via peroxisome proliferator-activated receptor alpha. J Biol Chem275: 12530—12536.
3.
Ernst E. (1999). Second thoughts about safety of St John's wort . Lancet354: 2014—2016.
4.
Ernst E., Rand JI, Barnes J., Stevinson C. (1998). Adverse effects profi le of the herbal antidepressant St. John's wort (Hypericum perforatum L.). Eur J Clin Pharmacol54: 589—594.
5.
Fugh-Berman A. (2000). Herb-drug interactions . Lancet355: 134 — 138.
6.
Fuhr U. (2000). Induction of drug metabolising enzymes: Pharmacokinetic and toxicological consequences in humans. Clin Pharmacokinet38: 493—504.
7.
Hertz R., Bar-Tana J. (1998). Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans. Toxicol Lett102—103: 85—90.
8.
Honkakoski P. , Zelko I., Sueyoshi T., Negishi M. (1998). The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol18: 5652—5658.
9.
Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD, Nicholas CO, Tomkinson NCO, LeCluyse EL, Lambert MH, Willson TM, Kliewer SA, Moore, JT (2000). The pregnane X receptor: A promiscuous xenobiotic receptor. Mol Endocrinol14: 27— 39.
10.
Kliewer SA, Lehmann JM, Willson TM (1999). Orphan nuclear receptors: Shifting endocrinology into reverse. Science284: 757— 760.
11.
Kliewer SA, Moore JT, Wade L., Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterstrom RH, Perlmann T., Lehmann JM (1998). An orphan nuclear receptor activated by pregnane s defi nes a novel steroid signaling pathway. Cell92: 73—82.
12.
Lambe KG, Woodyatt NJ, Macdonald N., Chevalier S., Roberts RA (1999). Species differences in sequence and activity of the peroxisome proliferator response element (PPRE) within the acyl CoA oxidase gene promoter. Toxicol Lett110: 119—127.
13.
Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions . J Clin Invest102: 1016—1023.
14.
Michalets EL (1998). Update: Clinically signifi cant cytochrome P-450 drug interactions. Pharmacotherapy18: 84—112.
15.
Moore, LB, Goodwin B., Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, Kliewer, SA (2000). St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA97: 7500—7502.
16.
Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B., Liddle C., Blanchard SG, Willson TM, Collins JL, Kliewer SA (2000). Orphan nuclear receptors CAR and PXR share xenobiotic and steroid ligands. J Biol Chem275: 15122—15127.
17.
Piscitelli SC, Burstein AH, Chaitt D., Alfaro RM, Falloon J. (2000). Indinavir concentrations and St John's wort. Lancet355: 547—548.
18.
Rodriguez C. , Noe V., Cabrero A., Ciudad CJ, Laguna JC (2000). Differences in the formation of PPARα-RXR/acoPPRE complexes between responsive and nonresponsive species upon fi brate administration. Mol Pharmacol58: 185—193.
19.
Ruschitzka F., Meier PJ, Turina M., Luscher TF, Noll G. (2000). Acute heart transplant rejection due to Saint John's wort. Lancet355: 548—549.
20.
Takada I., Yu RT, Xu HE, Lambert MH, Montana VG, Kliewer SA, Evans RM, Umesono K. (2000). Alteration of a single amino acid in peroxisome proliferator-activated receptor-alpha (PPAR α) generates a PPAR delta phenotype. Mol Endocrinol14: 733—740.
